Introduction: Since May 1992, feasibility, perioperative morbidity, early and long term sequelae as well as survival times following intraoperative radiotherapy are being examined. From our experience, the determination of the correct beam angle and electron energy is difficult by clinical means alone. Therefore, we devised a method for exact pretreatment planning and post-treatment dose verification. Materials and Methods: From May 1992 to October 1998, 50 patients with malignant gliomas of the brain were treated with IORT at our institution, 47 of which were evaluable at the time of analysis. 31 patients had a primary brain tumor, and 16 patients had recurrent tumors. The histological tumor types were distributed as fol-lows: glioma grade Ill (n = 22), and glioblastoma (n = 25). Treatment was carried out as 20 or 25 Gy electron-beam IORT (14 or 18 MeV), followed by 60 Gy postoperative radiation in not previously irradiated patients. The craniotomy was measured in all three dimensions, and the optimal beam angle and the depth of the tumour bed were determined using a neuronavigation system. Afterwards, computerized quality control was carried out by reconstruction of the beam angle and the use of a standard treatment planning system (CadPlan). Results: Perioperative complications were not increased (2 infections, 1 lethal haemorrhage and 1 malignant edema). 21/22 patients with increased brain pressure showed an improvement. Aphasia, hemiparesis, hemianopsia, psychosyndrom, gyrus angularis syndrom and convulsions were markedly reduced. i-year sutvival for all patients was 54%, 2-year survival 14%. Median survival was 12.5 months (glioma Ill: 13.5 months, glioblastoma IV: 11 months). Median time to progression was 7 months. The only prognostic factor was tumour grade (p = 0.04). Extent of resection, tumour size, age, KPI, and treatment had no significant influence. Conclusion: By using X-ray verification films, computerized quality control can be carried out after electron IORT. This way we could show that the neuronavigation method of pretreatment planning yields useful results. Side effects were not increased. Most tumour-associated symptoms could be alleviated. Compared to literature, median survival could be slightly improved.
Read full abstract